Guillaume Cohet, PharmD^1*, Cedrik NGO-Chin^2*, Nadia Douki^2*, Marion Desniaux^2*, Stellie Cornu^2*, Justine Nasone, PharmD^2*, Audrey Cras, PharmD, PhD^3*, Lionel Faivre, PharmD, PhD^2*, Nathalie Parquet, MD^4*, Anne Brignier, MD^4*, Dehbia Menouche, MD^5*, Emmanuelle Lesprit, MD^6*, Nabih Azar, MD^7*, Ramdane Belhocine, MD^8*, Isabelle Madelaine, PharmD^1*, Romain de JORNA, PharmD^9*, Jerome Larghero, PharmD, PhD^2* and Miryam Mebarki^10*

¹Pharmacy department, Saint-Louis Hospital, APHP, Paris, France
²Cell Therapy Unit, Saint-Louis Hospital, APHP, Paris, France
³Cell Therapy Unit, Saint Louis Hospital, APHP, Paris, France
⁴Apheresis, Saint-Louis Hospital, APHP, Paris, France
⁵Apheresis, Hopital Henri Mondor, Créteil, France
⁶Robert Debré Hospital, EFS, Paris, France
⁷Apheresis, La Pitié Salpétrière Hospital, APHP, Sorbonne Universite, Paris, France
⁸Apheresis, Saint Antoine Hospital, Paris, FRA
⁹Pharmacy department, Saint-Louis Hospital, APHP, Paris, FRA
¹⁰Cell Therapy Unit, Saint-Louis Hospital, APHP, University Paris Cité, Paris, France

Vladan Vucinic, M.D.^1*, Janine Kirchberg^1*, Mandy Brueckner^1*, Patrick Born^1*, Luise Fischer, PhD^1*, Enrica Bach^1*, Nora Grieb^1*, Simone Heyn^1*, Christina Kloetzer^1*, Klaus H Metzeler, MD¹, Sandra Hoffmann^1*, Carmen Herling, MD^1*, Marco Herling^1*, Georg-Nikolaus Franke^1*, Sebastian Schwind, MD^1*, Song-Yau Wang^1*, Madlen Jentzsch^1*, Uwe Platzbecker, MD² and Maximilian Merz, MD¹

¹Department of Hematology, Celltherapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
²University Leipzig Medical Center, Leipzig, Germany

Zachary David Crees, MD¹, Keith Stockerl-Goldstein, MD², Mark A. Schroeder, MD¹, Ravi Vij, MD, MBA¹, Ella Sorani, PhD^3*, Irit Gliko Kabir, PhD^3*, Inbal Goldstein^3*, Tzipi Lustig^4*, Shaul Kadosh^5* and John F. DiPersio, MD, PhD⁶

¹Division of Oncology, Washington University School of Medicine, Saint Louis, MO
²Washington University Internal Medicine, Saint Louis, MO
³BioLineRx Ltd., Modiin, Israel
⁴BioLineRx Ltd., Modi`In, Israel
⁵StatExcellence, Kyriat Mozkin, Israel
⁶Washington University School of Medicine, Saint Louis, MO

Moazzam Shahzad, MD^1,2, Joe S. Al-Ramahi^2*, Muhammad Kashif Amin, MD^3*, Muhammad Fareed Khalid, MD^2*, Shaun DeJarnette^2*, Zahra Mahmoudjafari, PharmD^2*, Maggie Nelson, PharmD^2*, Riley Hastings^3*, Haitham Abdelhakim, MD², Forat Lutfi, MD^2*, Nausheen Ahmed, MD^4,5*, Rajat Bansal, MD^2*, Leyla Shune, MD³, Al-Ola Abdallah, MD², Anurag K. Singh, MD², Sunil Abhyankar, MD², Joseph P McGuirk, DO^2,4 and Muhammad Umair Mushtaq, MD^2,4

¹H. Lee Moffitt Cancer Center, Tampa, FL
²University of Kansas Medical Center, Westwood, KS
³University of Kansas Medical Center, Kansas City, KS
⁴US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS

Yaojin Huang^1*, Mengyao Liu^1*, Xiaowei Xie^1*, Yawen Zhang^1,2*, Fang Dong^1*, Yingchi Zhang^1* and Tao Cheng^1,3

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
²Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
³Tianjin Institutes of Health Science, Tianjin, China